search

Active clinical trials for "Liver Diseases"

Results 861-870 of 1972

EVP-6124 Hepatic Impairment Study

Hepatic Impairment

The purpose of this study is to assess the pharmacokinetics of EVP-6124 and metabolites after a single oral dose in subjects with mild, moderate and severe hepatic impairment compared with subjects with normal hepatic function.

Completed29 enrollment criteria

A Study in Cancer Patients With Hepatic Impairment to Evaluate the Pharmacokinetics and Safety of...

Advanced or Metastatic Solid Tumors in Patients With Hepatic Impairment

The purpose of this study is to investigate the PK and safety of NKTR-102 in patients with mild, moderate, or severe hepatic impairment.

Completed19 enrollment criteria

Effect of Hepatic Impairment on LDK378 Pharmacokinetics

Normal Hepatic FunctionImpaired Hepatic Function

Pharmacokinetics and safety of 750 mg of LDK378 given once orally in subjects with impaired hepatic function and healthy subjects with normal hepatic function.

Completed9 enrollment criteria

Influence of Hepatic Impairment on Pharmacokinetic (PK) and Pharmacodynamic (PD) of Gemigliptin...

Hepatic Impairment

The trial will investigate the influence of hepatic function on the PK of gemigliptin. In an additional treatment period, the PK and safety of multiple dosing of gemigliptin in healthy White subjects will be investigated.

Completed8 enrollment criteria

Hepatic Dysfunction, Vitamin D Status, and Glycemic Control in Diabetes

Type 2 DiabetesNonalcoholic Fatty Liver Disease1 more

This study is designed to study the effect of vitamin D intake on the severity of fatty liver and poor glucose control in patients with type 2 diabetes and fatty liver disease.

Completed15 enrollment criteria

A Study of IDN-6556 in Subjects With NAFLD and Raised Transaminases

Nonalcoholic SteatohepatitisNon-alcoholic Fatty Liver Disease

The purpose of this study is to determine the safety and efficacy of IDN-6556 compared to placebo in patients with diagnosed fat deposits in their liver (not caused by alcohol) and with abnormal liver tests

Completed20 enrollment criteria

Usefulness of BiClamp Forceps for Liver Resection: A Randomized Clinical Trial

Hepatobiliary Disease

The purpose of this study is to compare short-term and long-term efficacy of BiClamp forceps hepatectomy and clamp-crushing technique for parenchymal transection during elective hepatic resection.

Completed13 enrollment criteria

Use of Omegaven Fish Oil Emulsion for Parenteral Nutrition Associated Liver Disease in Infants and...

Cholestasis

Use of a fish oil emulsion to decrease liver disease due to long term intravenous nutrition.

Completed6 enrollment criteria

Integrated Stepped Care for Unhealthy Alcohol Use in HIV

Liver DiseasesAlcoholic3 more

The study is a series of 3 linked randomized clinical trials of 6 month duration, with a total of 12 month follow-up, to evaluate the effect of Integrated Stepped Care on drinking outcomes and HIV biologic markers (including VACS index) in HIV-infected patients with unhealthy alcohol use.

Completed10 enrollment criteria

Pharmacokinetic, Pharmacodynamic and Tolerability Study of Otamixaban in Patients With Mild and...

Hepatic Impairment

Primary Objective: - To study effect of mild and moderate hepatic impairment on the pharmacokinetics of otamixaban. Secondary Objective: - To assess the pharmacodynamic effects of otamixaban on subjects with mild and moderate hepatic impairment and in matched subjects with normal hepatic function.

Completed15 enrollment criteria
1...868788...198

Need Help? Contact our team!


We'll reach out to this number within 24 hrs